Remains to be seen. Some traders always outsmart themselves. Just like fishermen who let the big one getaway :)
I state the obvious by responding each individual investor should evaluate their risk reward limits and choose accordingly. As far as research, this company's technology is far and beyond a leading disruptive force coming online to the biopharma world. Due your own due diligence. Best of luck!
Are now selling that inventory to new eyes due to the news. They knew what was coming. Not a fair playing field. Is it?
for this year and next. This message board is a joke. Once it provided valued information. Now, it is a playground for children. This is my last post here, for now. Good luck.
1. The ability to discern or judge what is true, right, or lasting; insight.
2. Common sense; good judgment.
3. The sum of learning through the ages; knowledge.
I would expect the FDA to fast track approval once submitted. Expedited by extensive BARDA study data already available.
Escalating revenues with expanding product offerings.
Expect a published item by tomorrow.
Anyone with intelligence can see that Mr Murphy is investor friendly and has provided as much transparency as possible to retail as well as institutional investors. He provides an equal playing field for all.